Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease

Sweeney, Melanie D, Sagare, Abhay P, Zlokovic, Berislav V·2015·Journal of Cerebral Blood Flow & Metabolism
DOI 10.1038/jcbfm.2015.76

Cites (224)

Items 201–225 of 225

  1. Plastic changes in the astrocyte GLUT1 glucose transporter and beta-tubulin microtubule protein following voluntary exercise in mice
    Angela Allen, Claude Messier · 2012 · Behavioural Brain Research
  2. Restoration of Cerebral and Systemic Microvascular Architecture in APP / PS 1 Transgenic Mice Following Treatment with Liraglutide™
    Patricia Kelly, Paula L. McClean, Maximilian Ackermann, Moritz Anton Konerding, Christian Hölscher, Christopher A. Mitchell · 2014 · Microcirculation
  3. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases
    Elke Bogaert, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht · 2006 · Muscle & Nerve
  4. Untitled work
    2007 · PubMed
  5. Biomarkers for Predicting Cognitive Decline in those with Normal Cognition
    Kyle Steenland, Alzheimer’s Disease Neuroimaging Initiative, Liping Zhao, Felicia C. Goldstein, Janet S. Cellar, James J. Lah · 2014 · Journal of Alzheimer s Disease
  6. Vascular signaling abnormalities in Alzheimer disease
    Paula Grammas, Alma C. Sanchez, Debjani Tripathy, Ester Luo, Joseph M. Martinez · 2011 · Cleveland Clinic Journal of Medicine
  7. Fibrinogen-Induced Increased Pial Venular Permeability in Mice
    Nino Muradashvili, Natia Qipshidze, Charu Munjal, Srikanth Givvimani, Richard L Benton, Andrew M. Roberts, Suresh C. Tyagi, David G. Lominadze · 2011 · Journal of Cerebral Blood Flow & Metabolism
  8. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Barbara Palumbo, Donatella Siepi, Isabella Sabalich, Cristina Tranfaglia, Lucilla Parnetti · 2008 · PubMed
  9. Cerebrospinal Fluid Markers of Pathogenetic Processes in Vascular Dementia, with Special Reference to the Subcortical Subtype
    Anders Wallin, Kaj Blennow, Lars Rosengren · 1999 · Alzheimer Disease & Associated Disorders
  10. Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8)
    Xue-Zhu Zhang, Guo-Min Li, Lin Guo, K. Nie, Yu-Jie Jia, Lan Zhao, J. Yu · 2013 · Neurological Sciences
  11. Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders
    Sharmilee Gnanapavan, Harald Hegen, Michael Khalil, Bernhard Hemmer, Diego M Franciotta, Steve G. Hughes, Rogier Q. Hintzen, Andreas Jeromin, Eva Havrdová, Hayrettin Tumani et al. · 2014 · Neurology
  12. Increased Permeability of the Blood-Brain Barrier and Alzheimer's Disease-Like Alterations in Slit-2 Transgenic Mice
    Jiangchao Li, Lu Han, Yin-xin Wen, Yongxia Yang, Shuai Li, Xue-song Li, Changjiang Zhao, Tingyu Wang, Hui Chen, Ying Liu et al. · 2014 · Journal of Alzheimer s Disease
  13. Vascular Plasticity and Cognition During Normal Aging and Dementia
    Axel Montagne, Judy Pa, Berislav V. Zloković · 2015 · JAMA Neurology
  14. Biological markers of Alzheimer?s disease
    Leonardo Cruz de Souza, Marie Sarazin, Antônio Lúcio Teixeira, Paulo Caramelli, Antonio Melo dos Santos, Bruno Dubois · 2014 · Arquivos de Neuro-Psiquiatria
  15. Increased levels of CSF phosphorylated tau in apolipoprotein E ɛ4 carriers with mild cognitive impairment
    Katharina Büerger, Stefan Johannes Teipel, Raymond P. Zinkowski, Trey Sunderland, Niels Andreasen, Kaj Blennow, Michael Ewers, John F. DeBernardis, Yong Shen, Daniel J. Kerkman et al. · 2005 · Neuroscience Letters
  16. A derivative of myelin‐associated glycoprotein in cerebrospinal fluid of normal subjects and patients with neurological disease
    Katsuhiko Yanagisawa, Richard H. Quarles, David Johnson, Roscoe O. Brady, John N. Whitaker · 1985 · Annals of Neurology
  17. Research Priority Setting
    Barbara G. Vickrey, Thomas G. Brott, Walter J. Koroshetz · 2013 · Stroke
  18. Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant
    Levy, Efrat, Prelli, Frances, Frangione, Blas · 2006 · Journal of Alzheimer's Disease
  19. Plasmin system of Alzheimer’s disease patients: CSF analysis
    Alessandro Martorana, Giulia Maria Sancesario, Zaira Esposito, Marzia Nuccetelli, Roberto Pietro Sorge, Amanda Formosa, Vincenzo Dinallo, Giorgio Bernardi, Sergio Bernardini, Giuseppe Sancesario · 2012 · Journal of Neural Transmission
  20. Spatial correlations between beta-amyloid (Abeta) deposits and blood vessels in familial Alzheimer's disease.
    Richard A. Armstrong · 2008 · PubMed
  21. Blood-Brain Barrier Disturbance in Patients with Alzheimer’s Disease is Related to Vascular Factors
    Kaj Blennow, Anders Wallin, Pam Fredman, Ingvar Karlsson, C. G. Gottfries, Lars T. Svennerholm · 1990 · Advances in behavioral biology
  22. Progress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
    Alan Rembach, Tim M. Ryan, Blaine Russell Roberts, James D. Doecke, W.J. Wilson, Andrew D. Watt, Kevin Jeffrey Barnham, Colin Louis Masters · 2013 · Biomarkers in Medicine
  23. Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the <i>PSEN1</i> gene
    Niwa, Atsushi, Matsuo, Ko, Shindo, Akihiro, Yata, Kenichiro, Shiraishi, Taizo, Tomimoto, Hidekazu · 2013 · Neuropathology
  24. Alzheimer’s Disease: New Data Highlight Nonneuronal Cell Types and the Necessity for Presymptomatic Prevention Strategies
    Sam Gandy · 2013 · Biological Psychiatry
  25. Biomarkers for neurology
    John O. Fleming, Cynthia M. Carlsson · 2014 · Neurology